BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 37989266)

  • 1. Toward Systems-Level Metabolic Analysis in Endocrine Disorders and Cancer.
    Lakhani A; Kang DH; Kang YE; Park JO
    Endocrinol Metab (Seoul); 2023 Dec; 38(6):619-630. PubMed ID: 37989266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cushing's syndrome is associated with altered adipokine profile.
    Dadej D; Szczepanek-Parulska E; Wrotkowska E; Ruchała M
    Front Endocrinol (Lausanne); 2022; 13():1032329. PubMed ID: 36561568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipogenesis in adipose tissue of patients with obesity and Cushing's disease.
    Galton DJ; Wilson JP
    Clin Sci; 1972 Dec; 43(6):17P. PubMed ID: 4264997
    [No Abstract]   [Full Text] [Related]  

  • 4. From Beats to Metabolism: the Heart at the Core of Interorgan Metabolic Cross Talk.
    Romero-Becera R; Santamans AM; Arcones AC; Sabio G
    Physiology (Bethesda); 2024 Mar; 39(2):98-125. PubMed ID: 38051123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome.
    Kola B; Christ-Crain M; Lolli F; Arnaldi G; Giacchetti G; Boscaro M; Grossman AB; Korbonits M
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4969-73. PubMed ID: 18782871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of obesity and Cushing's disease on the incorporation of glucose into lipid and esterification of palmitate by human adipose tissue.
    Wilson JP; Galton DJ
    Eur J Clin Invest; 1972 Nov; 2(6):379-83. PubMed ID: 4266190
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucose metabolism in Cushing's syndrome.
    Sharma A; Vella A
    Curr Opin Endocrinol Diabetes Obes; 2020 Jun; 27(3):140-145. PubMed ID: 32250974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolism of adipose tissue in normal humans and in various metabolic disorders. II. The adipose tissue in metabolic diseases].
    Sezille G; Jaillard J; Biserte G
    Ann Biol Clin (Paris); 1970; 28(3):209-15. PubMed ID: 5478256
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipid remodeling of adipose tissue in metabolic health and disease.
    Cho YK; Lee S; Lee J; Doh J; Park JH; Jung YS; Lee YH
    Exp Mol Med; 2023 Sep; 55(9):1955-1973. PubMed ID: 37653032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Adipose Tissue-Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer.
    Heyn GS; Corrêa LH; Magalhães KG
    Front Endocrinol (Lausanne); 2020; 11():563816. PubMed ID: 33123088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose tissue in control of metabolism.
    Luo L; Liu M
    J Endocrinol; 2016 Dec; 231(3):R77-R99. PubMed ID: 27935822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MECHANISMS IN ENDOCRINOLOGY: Tissue-specific activation of cortisol in Cushing's syndrome.
    Morgan SA; Hassan-Smith ZK; Lavery GG
    Eur J Endocrinol; 2016 Aug; 175(2):R83-9. PubMed ID: 26957494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cushing's syndrome: a model for sarcopenic obesity.
    Drey M; Berr CM; Reincke M; Fazel J; Seissler J; Schopohl J; Bidlingmaier M; Zopp S; Reisch N; Beuschlein F; Osswald A; Schmidmaier R
    Endocrine; 2017 Sep; 57(3):481-485. PubMed ID: 28702888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of the endocrine system in the pathogenesis of non-alcoholic fatty liver disease].
    Hagymási K; Reismann P; Rácz K; Tulassay Z
    Orv Hetil; 2009 Nov; 150(48):2173-81. PubMed ID: 19923096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of diabetes mellitus in Cushing's syndrome.
    Pivonello R; De Leo M; Vitale P; Cozzolino A; Simeoli C; De Martino MC; Lombardi G; Colao A
    Neuroendocrinology; 2010; 92 Suppl 1():77-81. PubMed ID: 20829623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical therapeutic approach in the management of diabetes mellitus secondary to Cushing's syndrome, acromegaly and neuroendocrine tumours.
    Guarnotta V; Emanuele F; Salzillo R; Bonsangue M; Amato C; Mineo MI; Giordano C
    Front Endocrinol (Lausanne); 2023; 14():1248985. PubMed ID: 37842314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is tissue cross-talk important in cancer cachexia?
    Johns N; Greig C; Fearon KC
    Crit Rev Oncog; 2012; 17(3):263-76. PubMed ID: 22831157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle and adipose tissue morphology and metabolism in Cushing's syndrome.
    Rebuffé-Scrive M; Krotkiewski M; Elfverson J; Björntorp P
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1122-8. PubMed ID: 3142910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose and lipid metabolism abnormalities in Cushing's syndrome.
    Salehidoost R; Korbonits M
    J Neuroendocrinol; 2022 Aug; 34(8):e13143. PubMed ID: 35980242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.